Health officials have given a life-extending drug the green light for widespread NHS, giving hope to thousands of men facing a "death sentence" from prostate cancer.
The National Institute for Health and Care Excellence (Nice) said the drug enzalutamide, also known as xtandi, should be considered for use in the treatment of men with hormone relapsed prostate cancer that has spread to other parts of the body.
Nice said in its draft guidance that it was pleased to recommend the drug, which is manufactured by Astellas Pharma, for patients who have few other treatment options left.
More top news
The number of diabetic and severely overweight patients having weight loss surgery needs to triple to help future NHS budgets, Nice said.
Scots may not have chosen independence but it seems Scotland, and it’s UK counterparts, could become more independent from one another.
Newsreader Michael Buerk has been given a lesson in rap by Tinchy Stryder in the I'm A Celebrity ... Get Me Out Of Here! jungle.